Company intelligence
CPTx
Pioneering the development of in vivo genetic medicines built with immune-quiet DNA.
Biotechnology Research
Planegg, DE
11–50 employees
Founded 2021
1 public signals
About CPTx
CPTx is a leader in developing the next generation of non-viral, DNA-based in vivo CAR T cell therapies, uniquely overcoming key challenges in both oncology and autoimmune disease. CPTx’s immune-quiet proprietary DNA platform enables control over the duration of gene expression from transient to permanent, supports the co-delivery of multiple genes, and allows for repeat administration.
Verified activity
Signals from CPTx
1 published signal